A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy

Biomedical Materials

Volumn 4, Issue 6, 2009, Pages

  Wu, Weigang ^a   Zheng, Qixin ^a   Guo, Xiaodong ^a   Sun, Jianhua ^a   Liu, Yudong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BONE; CELL CULTURE; HYDRAZINE; PRINTING; STEM CELLS; SULFUR COMPOUNDS; THREE DIMENSIONAL;

3-D PRINTING; BONE MARROW MESENCHYMAL STEM CELLS; COMPLEX CONSTRUCTION; CONCENTRIC CYLINDERS; CYTOCOMPATIBILITY; DRUG RELEASE; IN-VITRO; MULTI-LAYERED; PEAK CONCENTRATIONS; SPECIFIC SEQUENCES; THREE-DIMENSIONAL PRINTING;

DRUG THERAPY;

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG IMPLANT; DRUG MANUFACTURE; DRUG RELEASE; MESENCHYMAL STEM CELL; NONHUMAN; TUBERCULOUS OSTEOMYELITIS; ANIMAL; CYTOLOGY; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; MALE; METHODOLOGY; PHASE CONTRAST MICROSCOPY; POWDER; RABBIT; TUBERCULOUS ARTHRITIS;

ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTITUBERCULAR AGENTS; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; EQUIPMENT DESIGN; ISONIAZID; MALE; MESENCHYMAL STEM CELLS; MICROSCOPY, PHASE-CONTRAST; POWDERS; RABBITS; RIFAMPIN; TUBERCULOSIS, OSTEOARTICULAR;

EID: 73349091787     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/4/6/065005     Document Type: Article

References (40)

1. World Health Organization 2002 Global Tuberculosis Control WHO/CDS/TB/2002.295Surveillance, Planning, Financing WHO Report WHO/CDS/TB/2002.295 (Geneva, Switzerland: WHO)
2. Espinal M A, Laszlo A, Simonsen L, Boulahbal F and Rieder H L 2001 Global trends in resistance to antituberculosis drugs N. Engl. J. Med. 344 1294-303
3. Reichman L and Tanne J H 2001 Timebomb: The Global Epidemic of Multi-Drug Resistant Tuberculosis (New York: McGraw-Hill)
4. Raviglione M C and O'Brien R J 2001 Tuberculosis Harrison's Textbook of Medicine ed E Braunwald (New York: McGraw-Hill) pp 1024-35
5. Malaviya A N and Kotwal P P 2003 Arthritis associated with tuberculosis Best Pract. Res. Clin. Rheumatol. 17 319-43
6. Klemm K 1979 Gentamicin-PMMA-beads in treating bone and soft tissue infections Zentralbl. Chir. 104 934-42
7. Mendel V and Simanowski H J 2005 Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to staphylococcus aureus in rats Arch. Orthop. Trauma Surg. 125 363-8
8. Joosten U, Alexander J and Gosheger G 2005 Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of staphylococcus aureus induced chronic osteomyelitis Biomaterials 26 5251-8
9. Arlen D and Hanssen M D 2005 Local antibiotic delivery vehicles in the treatment of musculoskeletal infection Clin. Orthop. Relat. Res. 437 91-6
10. Gabriel T M, David G and Scott J 2002 Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures Biomaterials 23 1283-93
11. Zheng Q X, Guo X D and Du J Y 2002 Biodegradation of absorbable HA/dl-PLA composites in different environment J. Wuhan Univ. Technol., Mater. Sci. Ed. 17 24-9
12. Castro C, Sanchez E and Delgado A 2003 Ciprofloxacin implants for bone infection in vitro-in vivo characterization J. Control. Release 93 341-54
13. Jill K S, Susan L R and Robert P 2002 A three-dimensional osteochondral composite scaffold for articular cartilage repair Biomaterials 23 4739-51
14. Seitz H, Rieder W, Irsen S, Leukers B and Tille C 2005 Three-dimensional printing of porous ceramic scaffolds for bone tissue engineering J. Biomed. Mater. Res. B 74 782-8 (Pubitemid 41076949)
15. Sarah L T and Tejal A D 2003 Microfabricated drug delivery systems: from particles to pores Adv. Drug Deliv. Rev. 55 315-8
16. Wu B M, Borland S W, Giordano R A, Cima L G, Sachs E M and Cima M J 1996 Solid free-form fabrication of drug delivery devices J. Control. Release 40 77-87
17. Huang W D, Sun W Q, Zheng Q X and Yang X L 2005 Design and fabrication of drug delivery devices with complex architectures based on three-dimensional printing technique J. Wuhan Univ. Technol., Mater. Sci. Ed. 20 80-2
18. Huang W D, Zheng Q X, Sun W and Yang X L 2007 Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique Int. J. Pharm. 339 33-8
19. Wu W G and Zheng Q X 2009 The controlled-releasing drug implant based on the three dimensional printing technology: fabrication and properties of drug releasing in vivo J. Wuhan Univ. Technol.-Mater. Sci. Ed. at press
20. Lu Y and Chen S C 2004 Micro and nano-fabrication of biodegradable polymers for drug delivery Adv. Drug Deliv. Rev. 56 1621-33
21. Leong K F, Cheah C M and Chua C K 2003 Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs Biomaterials 24 2363-78
22. Sachols E, Reis N and Ainsley C 2003 Novel collagen scaffolds with prefined internal morphology made by solid freeform fabrication Biomaterials 24 1487-97
23. Wang C J, Calhoun J H and Mader J T 2002 The application of bioimplants in the management of chronic osteomyelitis Orthopedics 25 1247-52
24. Ambrose C G, Gogola G R, Clyburn T A, Raymond A K, Peng A S and Mikos A G 2003 Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis Clin. Orthop. Relat. Res. 415 279-85
25. Kanellakopoulou K and Giamarellos-Bourboulis E J 2000 Carrier systems for the local delivery of antibiotics in bone infections Drugs 59 1223-32
26. Hickmon S G, Skinner R A and Nelson C L 1998 Efficacy of treatment of experimental osteomyelitis with calcium sulfate pellets containing tobramycin 44th Ann. Meeting of the Orthopaedic Research Society (New Orleans, LA) p 427
27. Wang G H and Liu S J 2004 The release of cefazolin and gentamicin from biodegradable PLA/PGA beads Int. J. Pharm. 273 203-12
28. Ruszczak Z and Friess W 2003 Collagen as a carrier for on-site delivery of antibacterial drugs Adv. Drug Deliv. Rev. 55 1679-98
29. Yung H and Joseph G 1996 Low-density poly(dl-lactide-co-glycolide) foams for prolonged release of isoniazid J. Control. Release 40 293-302
30. Jones J R, Ahir S and Hench L L 2004 Large-scale production of 3D bioactive glass macro-porous scaffolds for tissue engineering J. Sol-Gel Sci. Technol. 29 179-88
31. Timmins G S and Deretic V 2006 Mechanisms of action of isoniazid Mol. Microbiol. 62 1220-7
32. Henry E, Doolittle W F and Neuhoff V 1973 Molecular Biology of Rifomycin (New York: MSS Inc.)
33. Coulson C J 1994 Molecular Mechanisms of Drug Action (Bristol, PA: Taylor & Francis)
34. Chein Y W 1992 Novel Drug Delivery Systems (New York: Dekker)
35. Collins RD 1985 Atlas of Drug Reactions (New York: Churchill Livingstone)
36. Kon E, Muraglia A, Corsi A, Bianco P, Marcacci M and Martin I 2000 Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones J. Biomed. Mater. Res. 49 328-37
37. Barry F P and Murphy J M 2004 Mesenchymal stem cells: clinical applications and biological characterization Int. J. Biochem. Cell Biol. 36 568-84
38. Wang Y W, Wu Q and Chen G Q 2004 Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate- co-3-hydroxyhexanoate) scaffolds Biomaterials 25 669-75
39. Xin X, Hussain M and Mao J J 2007 Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold Biomaterials 28 316-25
40. Li W J, Tuli R, Huang X, Laquerriere P and Tuan R S 2005 Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold Biomaterials 26 5158-66 (Pubitemid 40387839)